Pentixapharm Holding AG Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Equivalents	5.16	4.62	23.23
Cash & Short-Term Investments	5.16	4.62	23.23
Cash Growth	-70.31%	-80.10%	-
Accounts Receivable	0.02	0.03	6.81
Other Receivables	0.19	0.19	0.13
Total Trade Receivables	0.21	0.22	6.94
Other Current Assets	0.96	1.14	1.11
Total Current Assets	6.33	5.99	31.28
Net Property, Plant & Equipment	0.02	0.04	0.27
Other Intangible Assets	31.37	32.28	35.35
Long-Term Investments	0.22	0.23	0.48
Other Long-Term Assets	3.23	3.33	0.92
Total Assets	41.17	41.86	68.3
Accounts Payable	1.86	2.44	8.94
Other Current Liabilities	1.09	1.02	5.1
Total Current Liabilities	2.94	3.46	14.04
Other Long-Term Liabilities	6.07	3.33	3.93
Total Long-Term Liabilities	6.07	3.33	3.93
Total Liabilities	9.02	6.79	17.97
Common Stock	24.8	24.8	24.8
Treasury Stock	-0.01	-0.01	-0.01
Additional Paid-in Capital	38.99	38.73	37.48
Retained Earnings	-31.62	-28.44	-11.93
Shareholders' Equity	32.15	35.07	50.33
Total Liabilities & Equity	41.17	41.86	68.3
Net Cash (Debt)	5.16	4.62	23.23
Net Cash Growth	-70.31%	-80.10%	-
Net Cash Per Share	0.21	0.19	0.94
Book Value	32.15	35.07	50.33
Book Value Per Share	1.30	1.42	2.03
Tangible Book Value	0.78	2.79	14.98
Tangible Book Value Per Share	0.03	0.11	0.60